Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model

ISME Journal

Volumn 3, Issue 5, 2009, Pages 536-548

  Roesch, Luiz Fw ^a   Lorca, Graciela L ^a   Casella, George ^b   Giongo, Adriana ^a   Naranjo, Andres ^a   Pionzio, Arianna M ^a   Li, Nan ^c   Mai, Volker ^a   Wasserfall, Clive H ^c   Schatz, Desmond ^c   Atkinson, Mark A ^c   Neu, Josef ^c   Triplett, Eric W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

16S rRNA; 454 pyrosequencing; ARISA; Microbial diversity; Type 1 diabetes; UniFrac

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; RIBOSOMAL SPACER DNA; RIBOSOME DNA; RNA 16S;

ANIMAL; ARTICLE; BACTERIUM; BIODIVERSITY; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DIABETES MELLITUS; DNA SEQUENCE; GASTROINTESTINAL TRACT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY; RAT; RNA GENE; SEQUENCE HOMOLOGY;

ANIMALS; BACTERIA; BIODIVERSITY; CLUSTER ANALYSIS; DIABETES MELLITUS; DNA, BACTERIAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; GASTROINTESTINAL TRACT; GENES, RRNA; MOLECULAR SEQUENCE DATA; PHYLOGENY; RATS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES (CLASS); BIFIDOBACTERIUM; LACTOBACILLUS; RATTUS;

EID: 67349112373     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2009.5     Document Type: Article

References (54)

1. Altschul S, Madden T, Schaeffer A, Zhang J, Zhang Z, Miller W et al. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
2. Bernet-Camard MF, Lie'vin V, Brassart D, Neeser JR, Servin AL, Hudault S. (1997). The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63: 2747-2753.
3. Bosshard PP, Stettler R, Bachofen R. (2000). Seasonal and spatial community dynamics in the meromictic Lake Cadagno. Arch Microbiol 174: 168-174.
4. Brugman S, Klatter FA, Visser JTJ, Wildeboer-Veloo ACM, Harmsen HJM, Rozing J et al. (2006). Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49: 2105-2108.
5. Byun R, Nadkarni MA, Chhour KL, Martin FE, Jacques NA, Hunter N. (2004). Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 42: 3128-3136.
6. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S et al. (2005). Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48: 1565-1575.
7. Čepeljnik T, Lah B, Narat M, Marinšek-Logar R. (2007). Adaptation of adhesion test using caco-2 cells for anaerobic bacterium Pseudobutyrivibrio xylanivorans, a probiotic candidate. Folia Microbiol (Praha) 52: 367-373.
8. Čepeljnik T, Zorec M, Kostanjsek R, Nekrep FV, Marinsek-Logar R. (2003). Is Pseudobutyrivibrio xylanivorans strain Mz5T suitable as a probiotic? An in vitro study. Folia Microbiol (Praha) 48: 339-345.
9. Delroisse JM, Boulvin AL, Parmentier I, Dauphin RD, Vandenbol M, Portetelle D. (2008). Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol Res 163: 663-670.
10. DeSantis TZ, Hugenholtz P, Keller K, Brodie EL, Larsen N, Piceno YM et al. (2006). NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res 34: W394-W399.
11. Edgar RC. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32: 1792-1797.
12. Elder ME, Maclaren N. (1983). Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol 130: 1723-1731.
13. Fisher MM, Triplett EW. (1999). Automated approach for ribosomal intergenic spacer analysis of microbial diversity and its application to freshwater bacterial communities. Appl Environ Microbiol 65: 4630-4636.
14. Fukuda S, Suzuki Y, Murai M, Asanuma N, Hino T. (2006). Isolation of a novel strain of Butyrivibrio fibrisolvens that isomerizes linoleic acid to conjugated linoleic acid without hydrogenation, and its utilization as a probiotic for animals. J Appl Microbiol 100: 787-794.
15. Greiner DL, Rossin AA, Mordes JP. (2001). Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin Immunol 100: 134-143.
16. Hamady M, Walker J, Harris JK, Gold NJ, Knight R. (2008). Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5: 235-237.
17. Hooper LV. (2004). Bacterial contributions to mammalian gut development. Trends Microbiol 12: 129-134.
18. Hooper LV, Gordon JI. (2001). Commensal host-bacterial relationships in the gut. Science 292: 1115-1118.
19. Huang X, Wang J, Alum S, Yang SP, Hillier L. (2003). PCAP: a whole-genome assembly program. Genome Res 13: 2164-2170.
20. Hughes JB, Hellmann JJ, Ricketts TH, Bohannan BJM. (2001). Counting the uncountable: statistical approaches to estimating microbial diversity. Appl Environ Microbiol 67: 4399-4406.
21. Iwakoshi NN, Greiner DL, Rossini AA, Mordes JP. (1999). Diabetes prone BB rats are severely deficient in natural killer T cells. Autoimmunity 31: 1-14.
22. Jack RW, Tagg JR, Ray B. (1995). Bacteriocins from Gram-positive bacteria. Microbiol Rev 59: 171-200.
23. Klaenhammer T, Altermann E, Arigoni F, Bolotin A, Breidt F, Broadbent J et al. (2002). Discovering lactic acid bacteria by genomics. Antonie Van Leeuwenhoek 82: 29-58.
24. Leahy SC, Higgins DG, Fitzgerald GF, van Sinderen D. (2005). Getting better with bifidobacteria. J Appl Microbiol 98: 1303-1315.
25. Li W, Godzik A. (2006). Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22: 1658-1659.
26. Like AA, Guberski DL, Butler L. (1991). Influence of environmental viral agents on frequency and tempo of diabetes-mellitus in BB/WOR rats. Diabetes 40: 259-262.
27. Lorca GL, Wadstrom T, de Valdez GF, Ljungh A. (2001). Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 42: 39-44.
28. Lozupone C, Hamady M, Knight R. (2006). UniFrac - an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 7: 371.
29. Makarova K, Slesarev A, Wolf Y, Sorokin A, Mirkin B, Koonin E et al. (2006). Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci USA 103: 15611-15616.
30. min mice. Mol Carcinog 46: 42-48.
31. Martin B, Jofré A, Garriga M, Pla M, Aymerich T. (2006). Rapid quantitative detection of Lactobacillus sakei in meat and fermented sausages by real-time PCR. Appl Environ Microbiol 72: 6040-6048.
32. Matsuzaki T, Nagata Y, Kado S, Uchida K, Kato I, Hashimoto S et al. (1997). Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 105: 643-649.
33. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
34. McInerney MF, Pek SB, Thomas DW. (1991). Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40: 715-725.
35. Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. (2004). Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J 45: 278-291.
36. Neu J, Reverte CM, Mackey AD, Liboni K, Tuhacek-Tenace LM, Hatch M et al. (2005). Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 40: 589-595.
37. Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T. (2005). Oral administration of Butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 135: 2878-2883.
38. Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T. (2006). Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice. Clin Vaccine Immunol 13: 1231-1236.
39. Ranjard L, Poly LF, Lata JC, Mougel C, Thioulouse J, Nazaret S. (2001). Characterization of bacterial and fungal soil communities by automated ribosomal intergenic spacer analysis fingerprints: biological and methodological variability. Appl Env Microbiol 67: 4479-4487.
40. Reid G, Jass J, Sebulsky MT, McCormick JK. (2003). Potential uses of probiotics in clinical practice. Clin Microbiol Rev 4: 658-672.
41. Roesch LFW, Fulthorpe RR, Riva A, Casella G, Hadwin AKM, Kent AD et al. (2007). Pyrosequencing enumerates and contrasts soil microbial diversity. ISME J 1: 283-290.
42. Sadelain MWJ, Qin HY, Lauzon J, Singh B. (1990a). Prevention of type-1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589.
43. Sadelain MWJ, Qin HY, Sumoski W, Parfeny N, Singh B, Rabinovitch A. (1990b). Prevention of diabetes in the BB rat by early immunotherapy using Freund adjuvant. J Autoimmunity 3: 671-680.
44. Salminen S, Benno Y, de Vos W. (2006). Intestinal colonisation, microbiota and future probiotics? Asia Pac J Clin Nutr 15: 558-562.
45. Schwartz RF, Neu J, Schatz D, Atkinson MA, Wasserfall C. (2007). Comment on: Brugman S (2006). Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49: 2105-2108. Diabetologia 50: 220-221.
46. Silva M, Jacobus NV, Deneke C, Gorbach SL. (1987). Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 31: 1231-1213.
47. Stappenbeck TS, Hooper LV, Gordon JI. (2002). Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 99: 15451-15455.
48. Suzuki T, Yamada T, Fujimura T, Kawamura E, Shimizu M Yamashita R. (1987). Diabetogenic effects of lymphocyte transfusion on the NOD or NOD nude mouse. In: Rygaard J, Brunner N, Groem N, Spang-Thomsen M (eds). Immune-Deficient Animals in Biomedical Research, Copenhagen 1985. Karger: Basel, pp 112-116.
49. Tamura K, Dudley J, Nei M, Kumar S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
50. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higging DG. (1997). The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality tools. Nucleic Acids Res 25: 4876-4882.
51. Vaarala O, Atkinson MA, Neu J. (2008). The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
52. Vandenbergh PA. (1993). Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 12: 221-238.
53. Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y et al. (1987). Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 165: 1639-1654.
54. Yadav H, Shalini J, Sinha PR. (2007). Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23: 62-68.